These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29144590)

  • 21. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
    Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
    Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma.
    Hall Z; Chiarugi D; Charidemou E; Leslie J; Scott E; Pellegrinet L; Allison M; Mocciaro G; Anstee QM; Evan GI; Hoare M; Vidal-Puig A; Oakley F; Vacca M; Griffin JL
    Hepatology; 2021 Mar; 73(3):1028-1044. PubMed ID: 32460431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.
    Li YC; Yang CS; Zhou WL; Li HS; Han YJ; Wang QS; Wu HB
    World J Gastroenterol; 2018 Jan; 24(4):494-503. PubMed ID: 29398870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines.
    Boon R; Kumar M; Tricot T; Elia I; Ordovas L; Jacobs F; One J; De Smedt J; Eelen G; Bird M; Roelandt P; Doglioni G; Vriens K; Rossi M; Vazquez MA; Vanwelden T; Chesnais F; El Taghdouini A; Najimi M; Sokal E; Cassiman D; Snoeys J; Monshouwer M; Hu WS; Lange C; Carmeliet P; Fendt SM; Verfaillie CM
    Nat Commun; 2020 Mar; 11(1):1393. PubMed ID: 32170132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma.
    Zou J; Li H; Huang Q; Liu X; Qi X; Wang Y; Lu L; Liu Z
    Tumour Biol; 2017 Oct; 39(10):1010428317719272. PubMed ID: 29025375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells.
    Peng B; Liu F; Han R; Luo G; Cathopoulis T; Lu K; Li X; Yang L; Liu GY; Cai JC; Shi SL
    Int J Biochem Cell Biol; 2015 Sep; 66():45-58. PubMed ID: 26205150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
    Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.
    Ramesh V; Ganesan K
    Gene; 2016 Aug; 588(1):19-29. PubMed ID: 27107678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes.
    Wiśniewski JR; Vildhede A; Norén A; Artursson P
    J Proteomics; 2016 Mar; 136():234-47. PubMed ID: 26825538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma.
    Ferrarini A; Di Poto C; He S; Tu C; Varghese RS; Kara Balla A; Jayatilake M; Li Z; Ghaffari K; Fan Z; Sherif ZA; Kumar D; Kroemer A; Tadesse MG; Ressom HW
    J Proteome Res; 2019 Aug; 18(8):3067-3076. PubMed ID: 31188000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.
    Beyoğlu D; Imbeaud S; Maurhofer O; Bioulac-Sage P; Zucman-Rossi J; Dufour JF; Idle JR
    Hepatology; 2013 Jul; 58(1):229-38. PubMed ID: 23463346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from
    Chung YH; Tsai CK; Yu CF; Wang WL; Yang CL; Hong JH; Yen TC; Chen FH; Lin G
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Metabolomic Analysis Reveals Dynamic Metabolic Reprogramming in Hep3B Cells with Aflatoxin B1 Exposure.
    Wang S; Yang X; Liu F; Wang X; Zhang X; He K; Wang H
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34072178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomics Profiles of Hepatocellular Carcinoma in a Korean Prospective Cohort: The Korean Cancer Prevention Study-II.
    Jee SH; Kim M; Kim M; Yoo HJ; Kim H; Jung KJ; Hong S; Lee JH
    Cancer Prev Res (Phila); 2018 May; 11(5):303-312. PubMed ID: 29500188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of glaucocalyxin A on human liver cancer cells as revealed by GC/MS- and LC/MS-based metabolic profiling.
    Liu Y; Lu S; Zhao L; Dong X; Zhu Z; Jin Y; Chen H; Lu F; Hong Z; Chai Y
    Anal Bioanal Chem; 2018 May; 410(14):3325-3335. PubMed ID: 29651531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aqueous and lipid nuclear magnetic resonance metabolomic profiles of the earthworm Aporrectodea caliginosa show potential as an indicator species for environmental metabolomics.
    Brown JN; Samuelsson L; Bernardi G; Gooneratne R; Larsson DG
    Environ Toxicol Chem; 2014 Oct; 33(10):2313-22. PubMed ID: 24995628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis.
    Gao H; Lu Q; Liu X; Cong H; Zhao L; Wang H; Lin D
    Cancer Sci; 2009 Apr; 100(4):782-5. PubMed ID: 19469021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis.
    Teng CF; Hsieh WC; Yang CW; Su HM; Tsai TF; Sung WC; Huang W; Su IJ
    Mol Carcinog; 2016 Jan; 55(1):105-14. PubMed ID: 25594851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach.
    Gogna N; Krishna M; Oommen AM; Dorai K
    Mol Biosyst; 2015 Feb; 11(2):595-606. PubMed ID: 25464928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.